|Bid||0.00 x 1800|
|Ask||0.00 x 900|
|Day's range||14.31 - 15.69|
|52-week range||14.28 - 109.95|
|Beta (5Y monthly)||1.86|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2022 - 14 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||22.67|
Growth companies that have failed to deliver strong results over the last twelve months have taken a beating in the current bear market as investors want more than just promises of future growth. Two businesses that are struggling and haven't impressed investors this year are GoodRx Holdings (NASDAQ: GDRX) and Beyond Meat (NASDAQ: BYND). GoodRx Holdings, a company that provides customers with coupons on prescription medication, went public in September 2020.
Brands' (NYSE: YUM) Taco Bell announced they were finally releasing their first menu-item collaboration. In October, Taco Bell will test Beyond Carne Asada Steak at 50 restaurants in Ohio. This new menu item from Taco Bell is also Beyond Meat's first attempt at steak.
Motley Fool host Alison Southwick and Motley Fool personal finance expert Robert Brokamp talk with Motley Fool senior analyst Emily Flippen about some of the biggest consumer goods storylines of the year, and stocks to watch in the sector. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.